Moderna seeks DCGI approval for Covid-19 vaccine in India, Cipla applies for import licence

Moderna has sought an approval from the DCGI for its Covid-19 vaccine in India. Phrama major Cipla has applied for a licence to import and sell Moderna's Covid vaccine in India, as per government sources.

Moderna has sought approval for its Covid-19 vaccine in India. The Drug Controller General of India (DCGI) is likely to approve Moderna's Covid-19 vaccine for emergency use in those aged 18 and above, sources said on Tuesday. According to sources, pharmaceutical company Cipla has filed an application with the DCGI seeking permission to import Moderna's Covid-19 vaccine in India.